StockClub

INBX

INBXInhibrx Biosciences Inc.$ --
Inhibrx Biosciences Inc.

Inhibrx Biosciences Inc.

INBX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -100.0%
Operating Income
-31M USD
YoY +38.1%
Net Income
-33M USD
YoY +31.4%
EPS
-2.11$
YoY +36.3%

Revenue

$1.3M
FY2024 Q1$0
$0
Q1
FY2024 Q2$100,000
$100,000
Q2
FY2024 Q3$100,000
$100,000
Q3
FY2024 Q4$200,000
$200,000
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$1.3M
$1.3M
Q2
FY2025 Q3$1.3M
$1.3M
Q3
FY2025 Q4$1.3M
$1.3M
Q4
Actual
+$1.1M (+550.0%)

Net Income

$-140.1M
FY2024 Q1$-78.7M
$-78.7M
Q1
FY2024 Q2$1.8B
$1.8B
Q2
FY2024 Q3$1.7B
$1.7B
Q3
FY2024 Q4$1.7B
$1.7B
Q4
FY2025 Q1$-43.3M
$-43.3M
Q1
FY2025 Q2$-72M
$-72M
Q2
FY2025 Q3$-107.2M
$-107.2M
Q3
FY2025 Q4$-140.1M
$-140.1M
Q4
Actual
$-1.8B (-108.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$12.8M
Est:$11.1M
FY2020BEAT
$12.8M
FY2021BEAT
Actual:$7.1M
Est:$6.1M
FY2021BEAT
$7.1M
FY2022MISS
Actual:$2.2M
Est:$2.6M
FY2022MISS
$2.2M
FY2023BEAT
Actual:$1.8M
Est:$1.8M
FY2023BEAT
$1.8M
FY2024BEAT
Actual:$200,000
Est:$100,000
FY2024BEAT
$200,000
FY2025IN-LINE
Actual:$1.3M
Est:$1.3M
FY2025IN-LINE
$1.3M

Analyst Estimates